Hyperglycaemia is currently managed with an array of medications such as sulfonylureas, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, GLP-1 analogues, metformin and SGLT2 inhibitors (Keri, Samji & Blumenthal, 2018). This evidence concerns the gene DPP4 and Hyperglycemia.